Bausch Health Companies | VRX - Przychody Ze Sprzedaży





Obroty Zmiana Data
Amgen USD 10.1B 1.48B 2026-06
ANI Pharmaceuticals USD 266M 28.5M 2026-06
Aurora Cannabis CAD 38.01M 56.18M 2026-03
Bausch Health Companies USD 2.85B 350M 2026-06
Biogen USD 2.74B 490M 2026-06
Bristol-Myers Squibb USD 12.97B 1.48B 2026-06
Canopy Growth CAD 71.25M 3.29M 2026-03
Corcept Therapeutics USD 256.15M 91.25M 2026-06
Danaher USD 6.3B 350M 2026-06
Drreddys Laboratories INR 789.05M 86.48B 2026-03
Eli Lilly USD 22.97B 3.17B 2026-06
Gilead Sciences USD 7.8B 800M 2026-06
Nektar Therapeutics USD 10.86M 10.95M 2026-03
Novo Nordisk DKK 78.49B 18.33B 2026-06
Pacira USD 192.4M 15.4M 2026-06
Perrigo USD 1.02B 51M 2026-06
Phibro Animal Health USD 373.91M 10.02M 2025-12
Prestige Brands USD 265.71M 15.91M 2026-06
Supernus Pharmaceuticals USD 219.1M 11.39M 2026-06
Vertex Pharmaceuticals USD 3.33B 340M 2026-06
Zoetis USD 2.5B 200M 2026-06